Innovative Medical Technology CathWorks specializes in leveraging advanced computational science to transform coronary angiography into an objective FFR-based decision-making tool, providing hospitals and clinics with cutting-edge equipment that enhances diagnostic accuracy and treatment planning.
Strong Industry Recognition The company has received notable industry awards and is a finalist for the 2025 Octane High Tech Awards, highlighting its reputation as a leader in digital health innovations, which can open doors to strategic partnerships and clinical collaborations.
Robust Funding & Partnership With a significant investment of $75 million from Medtronic and strategic partnerships with organizations like Piccolo Medical and Hhmglobal, CathWorks demonstrates strong financial backing and a solid network to support market expansion.
Active Market Engagement Participation in key industry events such as EuroPCR 2025 and the successful enrollment in the ALL-RISE clinical study indicate ongoing efforts to validate and advance their medical technology, offering opportunities for direct engagement with healthcare providers and clinical stakeholders.
Growing Market Potential Operating in the medical equipment manufacturing industry with a revenue range of $10M to $25M and an expanding product portfolio, CathWorks is positioned to target hospitals and cardiology centers looking to adopt innovative, minimally invasive diagnostic tools, signaling ample sales opportunities in the cardiovascular market.